Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

13C-Methacetin Breath Test for the Prediction of Outcome in in Acute Liver Injury or Acute Liver Failure

NCT02786836 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT02786836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02786836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
13C-Methacetin Breath Test for the Prediction of Outcome in in Acute Liver Injury or Acute Liver Failure
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 2/3
Overall status
Completed
Start date
June 10, 2016
Completion date
September 18, 2019
Enrollment
76 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute liver failure